Severe Acute Respiratory Syndrome Coronavirus 2 Variant Delta Infects All 6 Siblings but Spares Comirnaty (BNT162b2, BioNTech/Pfizer)-Vaccinated Parents.
作者信息
Nathan Nadia, Prevost Blandine, Lambert Sidonie, Schnuriger Aurélie, Corvol Harriet
机构信息
Paediatric Pulmonology Department and Reference Centre for Rare Lung Disease RespiRare, Trousseau Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Sorbonne Université, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP), Paris, France.
出版信息
J Infect Dis. 2021 Dec 1;224(11):1984-1986. doi: 10.1093/infdis/jiab410.
Abstract
摘要
相似文献
1
Severe Acute Respiratory Syndrome Coronavirus 2 Variant Delta Infects All 6 Siblings but Spares Comirnaty (BNT162b2, BioNTech/Pfizer)-Vaccinated Parents.严重急性呼吸综合征冠状病毒2变异株德尔塔感染了所有6名兄弟姐妹，但未感染接种了科兴疫苗（BNT162b2，BioNTech/辉瑞）的父母。
J Infect Dis. 2021 Dec 1;224(11):1984-1986. doi: 10.1093/infdis/jiab410.
2
Status migrainosus: a potential adverse reaction to Comirnaty (BNT162b2, BioNtech/Pfizer) COVID-19 vaccine-a case report.Status migrainosus：一种潜在的辉瑞/ BioNtech（BNT162b2）COVID-19 疫苗不良反应-病例报告。
Neurol Sci. 2022 Feb;43(2):767-770. doi: 10.1007/s10072-021-05741-x. Epub 2021 Nov 22.
3
Effect of Pfizer/BioNTech and Oxford/AstraZeneca vaccines against COVID-19 morbidity and mortality in real-world settings at countrywide vaccination campaign in Saudi Arabia.辉瑞/生物科技和牛津/阿斯利康疫苗对沙特阿拉伯全国疫苗接种运动中真实环境下 COVID-19 发病率和死亡率的影响。
Eur Rev Med Pharmacol Sci. 2021 Nov;25(22):7185-7191. doi: 10.26355/eurrev_202111_27271.
4
Neutralisation of the SARS-CoV-2 Delta variant sub-lineages AY.4.2 and B.1.617.2 with the mutation E484K by Comirnaty (BNT162b2 mRNA) vaccine-elicited sera, Denmark, 1 to 26 November 2021.丹麦，2021 年 11 月 1 日至 26 日，用 Comirnaty（BNT162b2 mRNA）疫苗引发的血清对 SARS-CoV-2 Delta 变异株亚谱系 AY.4.2 和 B.1.617.2 中 E484K 突变的中和作用。
Euro Surveill. 2021 Dec;26(49). doi: 10.2807/1560-7917.ES.2021.26.49.2101059.
5
Tachycardia as an undescribed adverse effect to the Comirnaty© vaccine (BNT162b2 Pfizer-BioNTech Covid-19 vaccine): Description of 3 cases with a history of SARS-CoV-2 disease.心动过速作为Comirnaty©疫苗（辉瑞 - 生物科技公司的BNT162b2新冠疫苗）未描述的不良反应：3例有新冠病毒疾病史病例的描述
Enferm Infecc Microbiol Clin (Engl Ed). 2022 May;40(5):276-277. doi: 10.1016/j.eimce.2022.03.002. Epub 2022 Apr 26.
6
[Immune thrombocytopenia after BNT162b2 mRNA COVID-19 vaccination].[BNT162b2 mRNA新冠疫苗接种后免疫性血小板减少症]
Rinsho Ketsueki. 2021;62(11):1639-1642. doi: 10.11406/rinketsu.62.1639.
7
COVID-19 vaccines: comparison of biological, pharmacological characteristics and adverse effects of Pfizer/BioNTech and Moderna Vaccines.COVID-19 疫苗：辉瑞/生物科技和 Moderna 疫苗的生物学、药理学特征和不良反应比较。
Eur Rev Med Pharmacol Sci. 2021 Feb;25(3):1663-1669. doi: 10.26355/eurrev_202102_24877.
8
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Outbreak in a Long-term Care Facility After Vaccination With BNT162b2.接种BNT162b2疫苗后长期护理机构中出现严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫情。
Clin Infect Dis. 2021 Dec 6;73(11):2147-2148. doi: 10.1093/cid/ciab299.
9
COVID-19 Therapeutics and Vaccines: A Race to Save Lives.新冠病毒治疗方法和疫苗：一场拯救生命的竞赛。
Toxicol Sci. 2022 Jan 24;185(2):119-127. doi: 10.1093/toxsci/kfab130.
10
Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.立陶宛血液系统恶性肿瘤患者的 BNT162b2 COVID-19 mRNA 疫苗免疫原性和早期临床结局：一项全国前瞻性队列研究。
Lancet Haematol. 2021 Aug;8(8):e583-e592. doi: 10.1016/S2352-3026(21)00169-1. Epub 2021 Jul 2.
引用本文的文献
1
COVID-19 and pediatric pulmonology: Feedback from an expert center after the first year of the pandemic.COVID-19 与儿童肺病学：大流行第一年来自专家中心的反馈。
Pediatr Pulmonol. 2023 Feb;58(2):392-397. doi: 10.1002/ppul.26235. Epub 2022 Nov 22.
2
Risk factors for admission to the pediatric critical care unit among children hospitalized with COVID-19 in France.法国新冠病毒病住院儿童进入儿科重症监护病房的危险因素。
Front Pediatr. 2022 Sep 7;10:975826. doi: 10.3389/fped.2022.975826. eCollection 2022.
3
SARS-CoV-2 B.1.1.529 (Omicron) Variant Causes an Unprecedented Surge in Children Hospitalizations and Distinct Clinical Presentation Compared to the SARS-CoV-2 B.1.617.2 (Delta) Variant.严重急性呼吸综合征冠状病毒2型B.1.1.529（奥密克戎）变种导致儿童住院人数前所未有的激增，且与严重急性呼吸综合征冠状病毒2型B.1.617.2（德尔塔）变种相比，临床表现有所不同。
Front Pediatr. 2022 Jun 27;10:932170. doi: 10.3389/fped.2022.932170. eCollection 2022.
4
Clinical Epidemiology of Pediatric COVID-19 Delta Variant Cases From North Sumatra, Indonesia.印度尼西亚北苏门答腊省儿童新冠病毒德尔塔变异株病例的临床流行病学
Front Pediatr. 2022 Apr 1;10:810404. doi: 10.3389/fped.2022.810404. eCollection 2022.
5
How to Deal With Vaccine Breakthrough Infection With SARS-CoV-2 Variants.如何应对 SARS-CoV-2 变异株的疫苗突破性感染。
Front Public Health. 2022 Mar 15;10:842303. doi: 10.3389/fpubh.2022.842303. eCollection 2022.
6
BNT162b2 Vaccination during Pregnancy Protects Both the Mother and Infant: Anti-SARS-CoV-2 S Antibodies Persistently Positive in an Infant at 6 Months of Age.孕期接种BNT162b2疫苗可保护母婴：一名6个月大婴儿体内抗SARS-CoV-2 S抗体持续呈阳性。
Case Rep Pediatr. 2021 Oct 12;2021:6901131. doi: 10.1155/2021/6901131. eCollection 2021.
Zotero 插件